Clinical Trials on Addiction, Opioid in United Kingdom

Total 1678 results

University of Colorado, Denver
National Institute on Drug Abuse (NIDA)

Withdrawn

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4

Opioid-Related Disorders | Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine and Naloxone Combination Study - 10

Opioid-Related Disorders | Heroin Dependence

United States
Pain Therapeutics

Completed

Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse

Opioid-Related Disorders

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Entry Into Comprehensive Methadone Treatment Via Interim Maintenance

Opiate Dependence

United States
Washington University School of Medicine

Recruiting

Sex Hormones, Postoperative Pain and Opioid Use (SPO)

Postoperative Pain | Opioid Use

United States
University of Rochester
National Institute on Drug Abuse (NIDA)

Completed

The Association Between Loneliness and Substance Use

Loneliness | Opioid Use

United States
University of Arkansas

Completed

Video-based, Patient-Focused Opioid Education in the Perioperative Period

Opioid Use | Chronic Pain Post-Procedural

United States
AstraZeneca

Completed

A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Opioid-Induced Constipation (OIC)

United States, Germany, Australia, Slovakia
National Institute on Drug Abuse (NIDA)
Britannia Pharmaceuticals Ltd.

Completed

Lofexidine for Opiate Withdrawal - 1

Opioid-Related Disorders

United States
NEMA Research, Inc.
Food and Drug Administration (FDA)

Completed

Use of a Nurse Pain Educator for Patients With Chronic Pain

Chronic Pain | Opioid Use | Nurse's Role

United States
Rhode Island Hospital

Not yet recruiting

Ultrasound Guided Serratus Anterior Plane Block in ED Patients With Rib Fractures

Opioid Use | Rib Fractures | Regional Anesthesia | Pain Acute

United States
Cedars-Sinai Medical Center

Suspended

Virtual Reality After Breast Reconstruction Surgery (VR4BR)

Pain, Postoperative | Virtual Reality | Non-Opioid Pain Management

United States
San Francisco Department of Public Health

Completed

Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients (REBOOT)

Opioid-Related Disorders | Drug Overdose

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence

Opiate Dependence

United States
Yale University

Completed

Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance (Project BEST)

Opiate Dependence

United States
INSYS Therapeutics Inc

Completed

Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers

Opiate Dependence

United States
University of California, San Diego
Cadence Pharmaceuticals

Withdrawn

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Relationship Between Intraoperative Intravenous Acetaminophen and Postoperative Opioid Avoidance for Ambulatory Surgical Procedures (Cadence)

Postoperative Pain | Intraoperative and Postoperative Opioid Requirements

United States
National Institute on Drug Abuse (NIDA)

Completed

Methadone/Buprenorphine Cross-Over Study - 4

Opioid-Related Disorders

United States
Wake Forest University Health Sciences

Terminated

H-coil TMS to Reduce Pain: A Pilot Study Evaluating Relative Efficacy of the H1 vs H7 Coil

Healthy | Chronic Pain | Opioid Use | Pain, Chronic

United States
University of Pennsylvania
Yale University

Recruiting

Tau PET Imaging in Opioid Use Disorder

Opioid-Related Disorders

United States
Jacques E. Chelly
nCap Medical

Completed

A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery

Pain, Post Operative | Opioid Use

United States
Geisinger Clinic

Completed

Evaluation of a Medication Disposal Program in Primary Care

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Fetal Neurobehavioral Development in Methadone Maintained Pregnancies

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Improving Delivery of Mental Health Services for Patients With Drug Use and Other Behavioral and Emotional Problems

Study Focusing on Integrated Versus Non-integrated Psychiatric Care in | Opioid-dependent and Methadone Treated Patients With Other Psychiatric | Diagnoses

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Opioid Agonist and Antagonist Effects on Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate-Day Buprenorphine Administration. Phase VIII - 9

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Assessment of Tramadol as a Treatment for Opioid Addiction

Opioid-Related Disorders

United States
US Department of Veterans Affairs

Completed

Effect Of Case Management Following Discharge From Methadone Treatment

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase II - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VII - 8

Opioid-Related Disorders

United States
Indivior Inc.

Completed

Safety and Tolerability of Buprenorphine/Naloxone Film Strips

Opioid-Related Disorders

United States
Jacques E. Chelly
National Institute on Drug Abuse (NIDA); Masimo Corporation

Recruiting

Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement

Opioid Use | Cancer Pain | Auriculotherapy | Pain, Abdominal

United States
University of Maryland, Baltimore

Completed

Social Work Assistance and Stipends for Housing (SASH) (SASH)

Opioid-Related Disorders | Housing Problems

United States
Wayne State University
National Institute on Drug Abuse (NIDA)

Completed

Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects (YHO)

Opioid-Related Disorders | Heroin Dependence

United States
University of Pennsylvania

Completed

Remote Observed Dosing to Increase Suboxone Compliance (RODISC)

Opiate Dependence

United States
New York State Psychiatric Institute
Indivior Inc.

Completed

Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone

Heroin Dependence

United States
University of Colorado, Denver
National Institute on Drug Abuse (NIDA)

Withdrawn

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1

Opioid-Related Disorders | Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens

Opioid-Related Disorders | Heroin Dependence

United States
Wayne State University
National Institute on Drug Abuse (NIDA)

Completed

Effects of Stress and Other Factors on Opiate Drug Choice. (DSS)

Opioid-Related Disorders | Heroin Dependence

United States
Indiana University

Recruiting

Canine-Assisted Anxiety Reduction In Emergency Care (CANINE III)

Anxiety | Children | Opioid Use | Therapy Dog

United States
Johns Hopkins University

Completed

Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery (ORIOLES)

Prostate Cancer | Opioid Use

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Prescription Opioid Effects in Abusers Versus Non-Abusers

Substance-Related Disorders | Opioid-Related Disorders

United States

Clinical Trials on Addiction, Opioid in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations